The Effect of Stress on the Residual Gastric Volume
1 other identifier
observational
53
1 country
1
Brief Summary
In our institution, many patients undergo staged bilateral total knee arthroplasty at weekly intervals, and most of the patients are older adults with degenerative arthritis. As recommended, the older adult patients who undergoing total knee arthroplasty drink carbohydrate-containing fluid (400 ml) 2 hours prior to surgery. In this type of surgery, there are additional points to consider when applying the fasting guidelines. This is because, in addition to the factor of advanced age, which can affect gastric emptying time, the patient's physical, medical, and psychological conditions at the first and the second operation may be different. For example, the effect of the acute pain that occurs after the first total knee arthroplasty and subsequent opioids administered on gastric motility cannot be ignored. However, to date, there have been no studies examining the association of stress (emotional and surgical) and residual gastric volume of older adult patients with staged bilateral total knee arthroplasty and whether there is a difference according to the stage when carbohydrate-containing fluid is ingested. In the present study, the investigators will evaluate the effect of emotional stress, surgical stress, pain, and the use of opioids on the residual gastric volume in older adults undergoing staged-bilateral total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 6, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedJuly 5, 2022
July 1, 2022
1.2 years
June 1, 2022
July 1, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Level of stress hormone 1
Stress hormone (interleukin-1β, interleukin-6, interleukin-10, and tumor necrosis factor-α) measured after induction of spinal anesthesia
After induction of spinal anesthesia at first stage total knee arthroplasty/ an average 10 minutes
Level of stress hormone 2
Stress hormone (interleukin-1β, interleukin-6, interleukin-10, and tumor necrosis factor-α) measured after induction of spinal anesthesia
After induction of spinal anesthesia at second stage total knee arthroplasty/ an average 10 minutes
Secondary Outcomes (4)
Gastric volume 1
First stage operation, during the gastric volume measuring at preoperative holding area/ an average of 30 minutes
Gastric volume 2
Second stage operation, during the gastric volume measuring at preoperative holding area/ an average of 30 minutes
Anxiety scale 1
First stage operation, one day before surgery/ an average of 30 minutes
Anxiety scale 2
Second stage operation, one day before surgery/ an average of 30 minutes
Study Arms (1)
Group C
Patients drank carbohydrate fluid 2 hours prior to surgery.
Interventions
Eligibility Criteria
Study participants will be patients who are scheduled to undergo staged bilateral total knee arthroplasty requiring administration of carbohydrate-containing fluid 2 hours prior to surgery.
You may qualify if:
- Patients scheduled for staged bilateral total knee arthroplasty aged ≥ 65
- American Society of Anesthesiologists physical status classification 1, 2, and 3
- Body mass index \< 35 kg/cm2
- Patients administered carbohydrate-containing fluid 2 hours prior to surgery
You may not qualify if:
- Previous surgery of the upper gastrointestinal tract
- Achalasia
- Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Hyo-Seok Na, MD., PhD.
Seoul National University Bundang Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 1, 2022
First Posted
June 6, 2022
Study Start
July 1, 2022
Primary Completion
September 15, 2023
Study Completion
December 15, 2023
Last Updated
July 5, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share